Drivers of Commercially Viable
Cell Therapy Manufacturing

A Focus on Quality and Cost of Goods

Drivers of Commercially Viable Cell Therapy Manufacturing

When manufacturing a cell therapy product, it’s important to make sure that the manufacturing process is commercially viable. PCT has assembled a convenient resource outlining some key drivers of commercially viable cell therapy manufacturing—specifically the quality and cost of goods from the therapy product.

In this infographic, you’ll find:

  • An outline of Development by Design (DbD) and how it impacts quality, scalability, and cost of goods for a cell therapy product.
  • Information about phase-appropriate quality considerations.
  • Advice for achieving a commercial-ready quality state.
  • Outlines of the drivers for the cost of goods—including indirect costs that many forget about.

Download the infographic by filling out the form on this page now!

Access Your Infographic: